Haoxi Health Technology (HAO) Cash & Equivalents (2023 - 2025)

Haoxi Health Technology (HAO) has 3 years of Cash & Equivalents data on record, last reported at $8.6 million in Q2 2025.

  • For Q2 2025, Cash & Equivalents rose 29.49% year-over-year to $8.6 million; the TTM value through Jun 2025 reached $8.6 million, up 29.49%, while the annual FY2025 figure was $8.6 million, 29.49% up from the prior year.
  • Cash & Equivalents reached $8.6 million in Q2 2025 per HAO's latest filing, up from $6.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $8.6 million in Q2 2025 and bottomed at $1.2 million in Q2 2023.
  • Average Cash & Equivalents over 3 years is $5.5 million, with a median of $6.7 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 453.17% in 2024, then grew 29.49% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $1.2 million in 2023, then surged by 453.17% to $6.7 million in 2024, then rose by 29.49% to $8.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $8.6 million in Q2 2025, $6.7 million in Q2 2024, and $1.2 million in Q2 2023.